Works matching IS 09546820 AND DT 2010 AND VI 268 AND IP 3


Results: 10
    1
    2
    3
    4
    5
    6

    Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

    Published in:
    Journal of Internal Medicine, 2010, v. 268, n. 3, p. 296, doi. 10.1111/j.1365-2796.2010.02252.x
    By:
    • Eugen-Olsen, J.;
    • Andersen, O.;
    • Linneberg, A.;
    • Ladelund, S.;
    • Hansen, T. W.;
    • Langkilde, A.;
    • Petersen, J.;
    • Pielak, T.;
    • Møller, L. N.;
    • Jeppesen, J.;
    • Lyngbæk, S.;
    • Fenger, M.;
    • Olsen, M. H.;
    • Hildebrandt, P. R.;
    • Borch-Johnsen, K.;
    • Jørgensen, T.;
    • Haugaard, S. B.
    Publication type:
    Article
    7
    8
    9
    10